期刊文献+

Ad-ING4-IRES-IL-24双基因共表达载体的构建及表达 被引量:1

Construction and expression of adenovirus-mediated ING4 and IL-24 co-expression
下载PDF
导出
摘要 目的:构建IRES介导的携带人肿瘤生长抑制因子4(ING4)和人白介素24(IL-24)双基因的重组腺病毒共表达载体(简称为Ad-ING4-IRES-IL-24),研究其表达产物对A549肺癌细胞生长的影响。方法:将PCR扩增的IRES、ING4和IL-24基因片段分别插入pAdTrack-CMV载体中构建pAdTrack-CMV-ING4-IRES-IL-24双基因共表达重组转移载体。按腺病毒载体常规构建方法获得同源重组腺病毒质粒pAdEasy-1-pAdTrack-CMV-ING4-IRES-IL-24,并在QBI-293A包装细胞中进行包装和病毒扩增。将扩增后的Ad-ING4-IRES-IL-24腺病毒感染A549肺癌细胞,并用RT-PCR和Western blot法鉴定ING4和IL-24基因在QBI-293A细胞或A549肺癌细胞中的表达,MTT法和流式细胞仪检测其对A549肺癌细胞生长抑制和诱导凋亡的功能和抑癌增效作用。结果:DNA测序结果显示pAdTrack-CMV转移载体中插入的ING4、IRES和IL-24片段的序列与GenBank报道的完全一致,Ad-ING4-IRES-IL-24能成功介导ING4和IL-24基因在QBI-293A和A549细胞中表达,不仅能明显抑制A549肺癌细胞生长和诱导其凋亡(72小时生长抑制率为62.82%±0.65%,凋亡率为19.40%±1.29%),而且与Ad-ING4-IRES(72小时生长抑制率为42.31%±0.43%,凋亡率为13.30%±1.85%)和Ad-IRES-IL-24单基因组(72小时生长抑制率为47.44%±0.39%,凋亡率为12.40%±1.05%)相比具有显著性差异(P<0.05)。结论:成功构建了IRES介导的Ad-ING4-IL-24双基因共表达重组腺病毒载体,Ad-ING4-IL-24不仅能明显抑制A549肺癌细胞生长和诱导其凋亡,而且与Ad-ING4和AdIL-24单基因组相比具有抑癌增效作用。 Objective:To construct a recombinant adenoviral vector carrying and co-expressing human inhibitor of growth 4(ING4) and human interleukin-24(IL-24) mediated by internal ribosome entry site(IRES)(referred to as Ad-ING4-IRES-IL-24) and explore its effect on the growth of A549 human lung carcinoma cells in vitro.Methods:The IRES,ING4,and IL-24 fragments were amplified by PCR using pGEZ-Term,pcDNA3.0-IL-24,and pcDNA3.0-ING4 plasmids as templates and subcloned into pAdTrack-CMV transfer vector to form pAdTrack-CMV-ING4-IRES-IL-24,respectively.The pAdTrack-CMV-ING4-IRES-IL-24 transfer vector linearized with Pme Ⅰ digestion and pAdEasy-1 backbone vector were further cotransformed into the bacteria BJ5183 competent cells for homologous recombination.The resultant pAdEasy-1-pAdTrack-CMV-ING4-IRES-IL-24 homologous recombinant plasmids were linearized with Pac Ⅰ digestion and transfected into the human embryonic kidney 293(QBI-293A) cells by liposome,leading to formation of the recombinant adenoviruses Ad-ING4-IRES-IL-24 co-expressing ING4 and IL-24.Infected the A549 cells by the expanded adenoviruses Ad-ING4-IRES-IL-24,Adenovirus-mediated ING4 and IL-24 expression in QBI-293A and A549 cells was examined by RT-PCR and Western blot.The growth-suppressing and apoptosis-inducing effect of Ad-ING4-IRES IL-24 co-expressing ING4 and IL-24 on A549 human lung carcinoma cells were assessed by MTT assay and FCM,respectively.Results:DNA sequencing showed that the ING4,IRES,and IL-24 fragments subcloned into pAdTrack-CMV plasmids were completely identical to those reported in GenBank.ING4 and IL-24 gene mediated by adenovirus could both successfully express in QBI-293A and A549 cells.Adenovirus-mediated ING4 and IL-24 co-expression significantly suppressed A549 lung carcinoma cell growth and induced cell apoptosis.The adenoviral vector co-expressing ING4 and IL-24 mediated by IRES,Ad-ING4-IRES-IL-24,was successfully constructed.Adenovirus-mediated ING4 and IL-24 co-expression had marked anti-tumor effect in suppressing A549 human lung carcinoma cell growth and inducing cell apoptosis in vitro.Compared with Ad-ING4-IRES(growth inhibition ratio at 72 h was 42.31%±0.43%,apoptosis rate was 13.30%±1.85%) and Ad-IRES-IL-24(growth inhibition ratio at 72 h was 47.44%±0.39%,apoptosis rate was 12.40%±1.05%),Ad-ING4-IRES IL-24(growth inhibition ratio at 72 h is 62.82%±0.65%,apoptosis rate is 19.40%±1.29%) presented significant difference(P0.05).Conclusion:The adenoviral vector co-expressing ING4 and IL-24 mediated by IRES(Ad-ING4-IL-24) was successfully constructed.Ad-ING4-IL-24 had marked anti-tumor effect in suppressing A549 human lung carcinoma cells growth and inducing cell apoptosis in vitro.Compared with Ad-ING4 and Ad-IL-24,Ad-ING4-IL-24 enhanced anti-tumor effect.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2011年第8期701-708,共8页 Chinese Journal of Immunology
基金 国家自然科学基金资助项目(81001016) 江苏省卫生厅医学科研基金资助项目(No.H200914)
关键词 腺病毒 ING4 IL-24 肺癌 肿瘤基因治疗 Adenovirus Inhibitor of growth 4 Interleukin-24 Lung carcinoma Cancer gene therapy
  • 相关文献

参考文献10

二级参考文献61

  • 1唐云霞,陈瑜,顾锦法,齐荣,邹卫国,蒋琳兰,刘新垣.Ad.TERT-TRAIL对肿瘤细胞的杀伤作用及其机理[J].癌症,2005,24(5):536-542. 被引量:5
  • 2Li G Sham J Yang J Su C Xue H Chua D Sun L Zhang Q Cui Z Wu M Qian Q.Potent antitumor efficacy of an E1B 55kDa-deficient adenovirus carrying murine endostatin in hepatocellular carcinoma[J].第二军医大学学报,2005,26(11):1330-1330. 被引量:9
  • 3Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000, 100:57-70.
  • 4Salvesen GS, Duckett, CS. IAP proteins: blocking the road to death's door. Nat Rev Mol Cell Biol 2002, 3:401-410.
  • 5Altieri DC. Survivin, cancer networks and pathway-directed drug discovery. Nat Rev Cancer 2008, 8:61-70.
  • 6Dohi T, Beltrami E, Wall NR, Plescia J, Altieri DC. Mitochondrial survivin inhibits apoptosis and promotes tumorigenesis. J Clin Invest 2004, 114:1117-1127.
  • 7Song Z, Yao X, Wu M. Direct interaction between survivin and Smac/DIABLO is essential for the anti-apoptotic activity of survivin during taxol-induced apoptosis. J Biol Chem 2003, 278: 23130-23140.
  • 8Schultz IJ, Witjes JA, Swinkels DW, de Kok JB. Bladder cancer diagnosis and recurrence prognosis: comparison of markers with emphasis on survivin. Clin Chim Acta 2006, 368:20-32.
  • 9Parker AS, Kosari E Lohse CM, Thompson RH, Kwon ED, Murphy L, Riehle DL et al. High expression levels of survivin protein independently predict a poor outcome for patients who undergo surgery for clear cell renal cell carcinoma. Cancer 2006, 107:37-45.
  • 10Mesri M, Wall NR, Li J, Kim RW, Altieri DC. Cancer gene therapy using a survivin mutant adenovirus. J Clin Invest 2001, 108: 981990.

共引文献34

同被引文献28

  • 1Jiang H,Lin JJ,Su ZZ, et al. Subtraction hybridization identifies a novel melanomadifferentiation associated gene, mda-7,modulated during human melanoma differentiation ,growth and progression [j]. Oncogene, 1995,11(12):2477-2486.
  • 2Caadell EG,Mumm JB, Poindexter N ^et al. The protein product of the tumor suppressor gene, melanoma differentiation-associated gene 7,exhibits immunostim-ulatory activity and is designated IL-24[J]. Immunol, 2002, 168(12): 6041-6046.
  • 3Sunil C,Bryan R S,Suhendan E,et al. MDA-7 / IL-24 is a unique cytokine-tumor suppressor in the IL-10 family [J ]. Inter Immunopharmacology, 2004,4 (5): 649-667.
  • 4Denta P, Yacoub A,Hamed HA, et al. MDA-7/IL-24 as a cancer therapeutic ? from bench to bedside [J]. Anti-Cancer Drugs, 2010, 21(8):725-731.
  • 5Ramesh R,Ito I,Gopalan B,w al. Ectopic production of MDA-7/IL-24 inhibits invasion and migration of human lung cancer cellsQ]. Mol Ther, 2004,9 (4) : 510-518.
  • 6Su Z, Emdad L, Sauane M,et al. Unique aspects of mda-7/IL-24 antitumor bystander activity : establishing a role for secretion of MDA-7/IL-24 protein by normal cells[J]. Oncogene,2005?24(51) :7552-7566.
  • 7Chang S,Chen W ,Yang J , et al. Antitumor activity of an adenovirus harboring two therapeutic genes,anti-VEGF ribozyme and human IL-24,in colon cancer [J]. Mol Med Report, 2009,2(5)-.693-700.
  • 8Krisztina B,Oppenheim JJ, Zack Howard OM. Myeloid cells migrate in response to IL-24 [J]. Cytokine, 2011,55(3);429-434.
  • 9Bhutia SK,Dash R,Das SK,et al. Mechanism of au-tophagy to apoptosis switch triggered in prostate cancercells by antitumor cytokine melanoma differentiation-associated gene 7/interleukin-24 [ J ]. Cancer Res, 2010,70(9): 3667-3676.
  • 10Yacoub A,Liu R,Park M A, ^ al. Cisplatin enhances protein kinase R-like endoplasmic reticulum kinase-and CD95-dependent melanoma differentiation-associated gene-7/interleukin~24-induced killing in ovarian carcinoma cells [J]. Mol Pharmacol,2010, 77 (2): 298-310.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部